News
A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic ...
Zacks Investment Research on MSN2d
VALN Doses First Infant With Shigella Vaccine in Mid-Stage StudyShares of Valneva VALN rose 12% on Wednesday after the company announced that it has vaccinated the first participant in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback